Munafa Stock Market Course + Intraday & FNO calls 
ZYDUSLIFE NEWS why is Zydus Lifesciences Ltd price falling or rising
ZYDUSLIFE NEWS reasons for why stock price of Zydus Lifesciences Ltd is falling or rising
ZYDUSLIFE Zydus Lifesciences is falling or rising technical reasons
Technical analysis forecast of Zydus Lifesciences Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Zydus Lifesciences ZYDUSLIFE at this time. Stock is rising and might rise more.
It appears as if Zydus Lifesciences ZYDUSLIFE gave a large move recently.
Stock of Zydus Lifesciences (ZYDUSLIFE) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
Although my analysis for Zydus Lifesciences is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 925.7, for a target of 910.2 or 897.2
ZYDUSLIFE Zydus Lifesciences is falling or rising NEWS fundamental reasons
Company Announcement Zydus Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. - NEWS as on 2026-02-09
Q3 results: Pfizer, Zydus Lifesciences, Aurobindo Pharma, 181 more on Feb 9 Q3FY26 company results: Firms including GlaxoSmithKline Pharmaceuticals, The Ramco Cements, Linde India, Gulf Oil Lubricants, and Bata India are also to release their October-December earnings today - NEWS as on 2026-02-09 business-standard.com
Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of Sickle Cell Disease". - NEWS as on 2026-02-06
Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 04, 2026, titled "Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg". - NEWS as on 2026-02-04
Zydus Lifesciences hits the sweet spot after approval for generic diabetes drug Zydus Lifesciences has achieved a significant milestone by obtaining tentative approval from the US FDA for Dapagliflozin Tablets. Designed for individuals managing type 2 diabetes, these tablets will be produced in Ahmedabad. Notably, Dapagliflozin has pr - NEWS as on 2026-02-04 indiatimes.com
Company Announcement Zydus Lifesciences Limited has informed the Exchange about change in Management - NEWS as on 2026-02-01
Company Announcement Zydus Lifesciences Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-01-30
Company Announcement - NEWS as on 2026-01-28
Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 23, 2026, titled "Outcome of USFDA inspection". - NEWS as on 2026-01-27
Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 22, 2026, titled "Zydus launches the world s first biosimilar of Nivolumab, Tishtha , in India to treat multiple cancers". - NEWS as on 2026-01-22
Company Announcement Zydus Lifesciences Limited has informed the Exchange regarding 'Revision in ESG Rating'. - NEWS as on 2026-01-20
Company Announcement Zydus Lifesciences Limited has informed the Exchange about General Updates - NEWS as on 2026-01-19
More announcements and NEWS
ZYDUSLIFE Zydus Lifesciences Ltd current price & indicator signals
Recent prices of ZYDUSLIFE Zydus Lifesciences Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 09 Mon Feb 2026 | 923.45 | 884.00 to 933.35 | 3.97% | 4.25 times |
| 06 Fri Feb 2026 | 888.15 | 884.00 to 905.00 | -1.86% | 1 times |
| 05 Thu Feb 2026 | 905.00 | 896.60 to 910.00 | -0.03% | 0.85 times |
| 04 Wed Feb 2026 | 905.25 | 898.65 to 912.50 | 0.26% | 1.01 times |
| 03 Tue Feb 2026 | 902.90 | 895.25 to 916.85 | 2.64% | 2.14 times |
| 02 Mon Feb 2026 | 879.65 | 863.65 to 882.00 | 0.18% | 0.83 times |
| 01 Sun Feb 2026 | 878.10 | 875.95 to 897.00 | -0.81% | 0.35 times |
| 30 Fri Jan 2026 | 885.30 | 882.45 to 896.15 | -0.61% | 1.35 times |
| 29 Thu Jan 2026 | 890.70 | 881.15 to 894.00 | -0.69% | 0.82 times |
| 28 Wed Jan 2026 | 896.90 | 886.45 to 899.20 | 0.4% | 0.64 times |
| 27 Tue Jan 2026 | 893.35 | 879.90 to 894.95 | 1.29% | 1 times |
| 23 Fri Jan 2026 | 882.00 | 880.00 to 897.15 | -0.37% | 0.94 times |
Videos related to: ZYDUSLIFE NEWS why is Zydus Lifesciences Ltd price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
